Search
Metandienone
go.drugbank.com/drugs/DB13586ApprovedWithdrawnAlthough it is prohibited in and outside competition by the World Anti-Doping Agency, metandienone continues to be marketed and misused as a performance-enhancing drug in sports. … It was introduced to the market in the 1960s but later discontinued and withdrawn from the market.
Products: SIROBOLIN ŞURUP, 120 ML, เมตาโบลอน 20Ibutilide
go.drugbank.com/drugs/DB00308ApprovedIt is indicated for the conversion of acute atrial flutter and recent onset atrial fibrillation to normal sinus rhythm (NSR).
Products: Fybrio 1 mg/10 ml I.V. Enjeksiyonluk Çözelti, 1 ADET, Corvert 87 Mikrogramm/ml InfusionslösungLisdexamfetamine
go.drugbank.com/drugs/DB01255ApprovedInvestigational[A2230] Lisdexamfetamine is the first chemically formulated prodrug stimulant [A40246] and was first approved by the FDA in April 2008.[A2230] It was also approved by Health Canada in February 2009. … Lisdexamfetamine is a prodrug of [dextroamphetamine], a central nervous system stimulant known as d-amphetamine,[A40246] covalently attached to the naturally occurring amino acid L-lysine.
Products: VYVANSE CAPSULES 20 mg, VYVANSE® 20 MG CAPSULASInterferon beta-1b
go.drugbank.com/drugs/DB00068ApprovedInvestigationalProduced in E. coli, no carbohydrates, MW=18.5kD
Products: BETAFERON FOR INJECTION 0.25 mg/mlPlasma protein fraction (human)
go.drugbank.com/drugs/DB13968ApprovedInvestigationalIt is also stated that no more than 1% of the total protein should be gamma globulin.[L2260] PPFh is a sterile, frozen solution of solvent/detergent treated human plasma. … The composition of PPFh should be 5% of protein from which 83% should consist of albumin and no more of 17% should be globulin.
Mixtures: /ml InfusionslösungProducts: OCTAPLAS LG, PLASMANATE - 5% ( 250 ML VIAL )Hydrocortisone succinate
go.drugbank.com/drugs/DB14545ApprovedInvestigationalProducts: SOLU-CORTEF FOR INJECTION 100 mg/vial, SOLU-CORTEF® 100 MG POLVO PARA INYECCIONPentoxyverine
go.drugbank.com/drugs/DB11186ApprovedWithdrawnPentoxyverine acts on sigma-1 receptors, as well as kappa and mu-opioid receptors. The FDA withdrew the use of all oral gel drug products containing pentoxyverine citrate. … [L43942] Other forms of pentoxyverine citrate continue to be marketed.
Mixtures: GAYABEN 150 ML SURUP, Corzall PEProducts: PENTOXYVERIN AL 1.35 MG/ML, Mucomat Hustenstiller 2,13 mg/ml Lösung zum EinnehmenLacidipine
go.drugbank.com/drugs/DB09236ApprovedIt is available as once-daily oral tablets containing 2 or 4 mg of the active compound commonly marketed as Lacipil or Motens. It is not currently FDA-approved. … In randomised, well-controlled trials, administration of daily single-dose lacidipine ranging from 2-6 mg demonstrated comparable antihypertensive efficacy similar to that of other long-acting dihydropyridine
Products: LACIDIPINA EG, LACIPIL TABLET 4 mgLevomenthol
go.drugbank.com/drugs/DB00825ApprovedInvestigationalMenthol mediates anesthetic properties and anti-irritating properties locally, thus it is widely used to relieve minor throat irritations. … Forming clear or white waxy, crystalline substance, menthol is typically solid at room temperature. (-)-Menthol is the naturally-occurring and main form of menthol, and is assigned the (1R,2S,5R) configuration
Mixtures: KAMFOLIN 150 MG/G+100 MG/G MERHEM, 50 G, TANOL 100 ML LOSYONSynonyms: L-menthol, L-(-)-MENTHOLRemifentanil
go.drugbank.com/drugs/DB00899ApprovedInvestigationalRemifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.
Products: RAFENTILO®INYECTABLE 2.0 MG, REMIFENTANILO 1 MG/ML